• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Sanofi says arbitration court rejects Boehringer's Zantac claims

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 21, 2023 at 11:02: AM
via Sanofi (SASY.PA) said on Tuesday that the International Chamber of Commerce rejected rival drugmaker Boehringer Ingelheim's (BI) claims to be indemnified by Sanofi in cancer lawsuits linked to heartburn drug Zantac in the United States.

article source
 




Top Bottom
Back
Quote